Comparative efficacy of non-statin lipid-lowering therapies in patients with hypercholesterolemia at increased cardiovascular risk: a network meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy of non-statin lipid-lowering therapies in patients with hypercholesterolemia at increased cardiovascular risk: a network meta-analysis

Published:2022-03-20 Issue:5 Volume:38 Page:777-784
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Burnett Heather¹,Fahrbach Kyle²,Cichewicz Allie²,Jindal Ramandeep³,Tarpey Jialu²,Durand Adeline⁴,Di Domenico Maximiliano⁵,Reichelt Andreas⁵,Viljoen Adie⁶

Affiliation:

1. Evidera, St-Laurent, Canada

2. Evidera, Waltham, MA, USA

3. Novartis Healthcare Pvt Ltd., Salarpuria-Sattva Knowledge City, HITEC City, Hyderabad, India

4. Novartis, Pharma UK, London, UK

5. Novartis, Pharma AG, Basel, Switzerland

6. Borthwick Diabetes Research Unit, Lister Hospital, Hertfordshire, UK

Funder

Novartis Pharma AG

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2049164

Reference56 articles.

1. Diagnosis, management and prognosis of familial hypercholesterolaemia in a UK tertiary cardiac centre

2. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry

3. World Health Organization (WHO). WHO global health observatory data, Raised Cholesterol 2020. Available from: https://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/.

4. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

5. Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Drug: Inclisiran for hypercholesterolaemia;Australian Prescriber;2024-06-18

2. Laser therapy and unloading therapeutic gymnastics in the treatment of dyslipoproteinemia;Medicine of Extreme Situations;2024-03

3. Short-Course High-Intensity Statin Treatment during Admission for Myocardial Infarction and LDL-Cholesterol Reduction—Impact on Tailored Lipid-Lowering Therapy at Discharge;Journal of Clinical Medicine;2023-12-25

4. Inclisiran for the Treatment of Hyperlipidemia and for Atherosclerotic Cardiovascular Disease Risk Reduction: A Narrative Review;Clinical Therapeutics;2023-11

5. Novel Low-Density Lipoprotein Cholesterol Reduction Therapies for the Secondary Prevention of Cardiovascular Disease;Reviews in Cardiovascular Medicine;2023-10-08